Ipilimumab vs Valproic Acid
Ipilimumab vs Valproic Acid: Overview
This comparison examines the pharmacological differences between Ipilimumab and Valproic Acid.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Valproic Acid: Enhances GABA transmission and blocks sodium/calcium channels.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Valproic Acid β 9-16 hours.
Chemical Properties
Molecular Formula: Valproic Acid β C8H16O2.
Molecular Weight: Valproic Acid β 144.2110 g/mol.
Type: Ipilimumab β Antibody; Valproic Acid β Small molecule.